Multiple myeloma: the (r)evolution of current therapy and a glance into future.
Sign Up to like & getrecommendations! Published in 2020 at "Haematologica"
DOI: 10.3324/haematol.2020.247015
Abstract: Over the past 20 years, the regulatory approval of several novel agents to treat multiple myeloma (MM) has prolonged median patient survival from 3 to 8-10 years. Increased understanding of MM biology has translated to… read more here.
Keywords: myeloma; multiple myeloma; therapy glance; current therapy ... See more keywords